KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Interest Expenses (2017 - 2024)

Historic Interest Expenses for Bionano Genomics (BNGO) over the last 8 years, with Q1 2024 value amounting to $122000.0.

  • Bionano Genomics' Interest Expenses rose 6052.63% to $122000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $122000.0, marking a year-over-year decrease of 9761.67%. This contributed to the annual value of $5.1 million for FY2023, which is 161778.52% up from last year.
  • Bionano Genomics' Interest Expenses amounted to $122000.0 in Q1 2024, which was up 6052.63% from $4.9 million recorded in Q4 2023.
  • Bionano Genomics' 5-year Interest Expenses high stood at $4.9 million for Q4 2023, and its period low was $2000.0 during Q3 2021.
  • Moreover, its 5-year median value for Interest Expenses was $77000.0 (2022), whereas its average is $528882.4.
  • As far as peak fluctuations go, Bionano Genomics' Interest Expenses tumbled by 9966.04% in 2021, and later surged by 643066.67% in 2023.
  • Quarter analysis of 5 years shows Bionano Genomics' Interest Expenses stood at $608000.0 in 2020, then crashed by 95.56% to $27000.0 in 2021, then soared by 177.78% to $75000.0 in 2022, then surged by 6430.67% to $4.9 million in 2023, then plummeted by 97.51% to $122000.0 in 2024.
  • Its Interest Expenses was $122000.0 in Q1 2024, compared to $4.9 million in Q4 2023 and $71000.0 in Q3 2023.